Figure 1From: Indacaterol on dyspnea in chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized placebo-controlled trials Forest plot of odds ratios and 95% confidence intervals. Relative to placebo, patients receiving indacaterol 75 μg once daily are more likely to achieve TDI score equal to or greater than one unit.Back to article page